O	0	6	EduCan
O	7	12	trial
O	12	13	:
O	14	19	study
O	20	28	protocol
O	29	32	for
O	33	34	a
O	35	45	randomised
O	46	56	controlled
O	57	62	trial
O	63	65	on
O	66	69	the
O	70	83	effectiveness
O	84	86	of
B-intervention	87	91	pain
I-intervention	92	104	neuroscience
I-intervention	105	114	education
O	115	120	after
O	121	127	breast
O	128	134	cancer
O	135	142	surgery
O	143	145	on
B-condition	146	150	pain
I-condition	150	151	,
I-condition	152	160	physical
I-condition	160	161	,
I-condition	162	171	emotional
I-condition	172	175	and
I-condition	176	180	work
I-condition	180	181	-
I-condition	181	188	related
I-condition	189	200	functioning
O	200	201	.

O	202	206	Over
O	207	210	the
O	211	215	past
O	216	223	decades
O	223	224	,
O	225	234	awareness
O	235	237	on
O	238	241	the
O	242	252	importance
O	253	255	of
O	256	267	educational
O	268	281	interventions
O	282	284	in
O	285	291	cancer
O	292	296	pain
O	297	307	management
O	308	311	has
O	312	321	increased
O	321	322	.

O	323	330	However
O	330	331	,
O	332	341	education
O	342	344	is
O	345	350	often
O	351	361	restricted
O	362	364	to
O	365	375	biomedical
O	376	380	pain
O	381	391	management
O	392	404	instructions
O	404	405	.

O	406	407	A
O	408	412	more
O	413	419	modern
O	420	431	educational
O	432	440	approach
O	440	441	,
O	442	446	also
O	447	452	known
O	453	455	as
O	456	460	pain
O	461	473	neuroscience
O	474	483	education
O	484	485	(
O	485	488	PNE
O	488	489	)
O	489	490	,
O	491	499	explains
O	500	504	pain
O	505	509	from
O	510	511	a
O	512	527	biopsychosocial
O	528	539	perspective
O	539	540	.

O	541	543	We
O	544	555	hypothesise
O	556	560	that
O	561	565	this
O	566	570	more
O	571	584	comprehensive
O	585	596	educational
O	597	605	approach
O	606	608	in
O	609	612	the
O	613	618	early
O	619	628	treatment
O	629	634	phase
O	635	637	of
O	638	644	breast
O	645	651	cancer
O	652	656	will
O	657	661	lead
O	662	664	to
O	665	669	more
O	670	680	beneficial
O	681	688	effects
O	689	692	for
O	693	699	cancer
O	700	704	pain
O	705	715	management
O	715	716	.

O	717	726	Therefore
O	726	727	,
O	728	731	the
O	732	735	aim
O	736	738	of
O	739	742	the
O	743	750	present
O	751	756	study
O	757	759	is
O	760	762	to
O	763	774	investigate
O	775	778	the
O	779	792	effectiveness
O	793	795	of
O	796	800	this
O	801	804	PNE
O	805	817	intervention
O	817	818	,
O	819	821	in
O	822	830	addition
O	831	833	to
O	834	838	best
O	839	847	evidence
O	848	856	physical
O	857	864	therapy
O	865	875	modalities
O	876	879	for
O	880	889	treatment
O	890	893	and
O	894	904	prevention
O	905	907	of
O	908	912	pain
O	912	913	,
O	914	922	physical
O	922	923	,
O	924	933	emotional
O	934	937	and
O	938	942	work
O	942	943	-
O	943	950	related
O	951	962	functioning
O	963	968	after
O	969	975	breast
O	976	982	cancer
O	983	990	surgery
O	990	991	,
O	992	1000	compared
O	1001	1005	with
O	1006	1007	a
B-control	1008	1019	traditional
I-control	1020	1030	biomedical
I-control	1031	1042	educational
I-control	1043	1055	intervention
O	1055	1056	.

O	1057	1058	A
O	1059	1065	double
O	1065	1066	-
O	1066	1073	blinded
O	1074	1084	randomised
O	1085	1095	controlled
O	1096	1101	trial
O	1102	1105	has
O	1106	1110	been
O	1111	1118	started
O	1119	1121	in
O	1122	1130	November
O	1131	1135	2017
O	1136	1138	at
O	1139	1142	the
O	1143	1153	University
O	1154	1163	Hospitals
O	1164	1166	of
B-location	1167	1173	Leuven
O	1173	1174	.

O	1175	1186	Immediately
O	1187	1192	after
O	1193	1199	breast
O	1200	1206	cancer
O	1207	1214	surgery
O	1214	1215	,
O	1216	1219	all
O	1220	1232	participants
O	1233	1234	(
O	1234	1235	n
O	1235	1236	=
B-total-participants	1236	1239	184
O	1239	1240	)
O	1241	1248	receive
O	1249	1250	a
O	1251	1253	12
O	1253	1254	-
O	1254	1258	week
O	1259	1268	intensive
O	1269	1277	standard
O	1278	1286	physical
O	1287	1294	therapy
O	1295	1304	programme
O	1304	1305	.

O	1306	1310	They
O	1311	1318	receive
O	1319	1324	three
O	1325	1335	additional
O	1336	1345	refresher
O	1346	1354	sessions
O	1355	1357	at
O	1358	1359	6
O	1359	1360	,
O	1361	1362	8
O	1363	1366	and
O	1367	1369	12
O	1370	1376	months
O	1377	1388	postsurgery
O	1388	1389	.

O	1390	1392	In
O	1393	1401	addition
O	1401	1402	,
O	1403	1415	participants
O	1416	1423	receive
O	1424	1429	three
O	1430	1441	educational
O	1442	1450	sessions
O	1451	1457	during
O	1458	1461	the
O	1462	1467	first
O	1467	1468	-
O	1468	1473	month
O	1474	1485	postsurgery
O	1486	1489	and
O	1490	1495	three
O	1496	1497	'
O	1497	1504	booster
O	1505	1513	sessions
O	1513	1514	'
O	1515	1517	at
O	1518	1519	6
O	1519	1520	,
O	1521	1522	8
O	1523	1526	and
O	1527	1529	12
O	1530	1536	months
O	1537	1548	postsurgery
O	1548	1549	.

O	1550	1552	In
O	1553	1556	the
O	1557	1569	intervention
O	1570	1575	group
O	1575	1576	,
O	1577	1580	the
O	1581	1588	content
O	1589	1591	of
O	1592	1595	the
O	1596	1605	education
O	1606	1614	sessions
O	1615	1617	is
O	1618	1623	based
O	1624	1626	on
O	1627	1630	the
O	1631	1637	modern
O	1638	1641	PNE
O	1642	1650	approach
O	1650	1651	.

O	1652	1659	Whereas
O	1660	1662	in
O	1663	1666	the
O	1667	1674	control
O	1675	1680	group
O	1680	1681	,
O	1682	1685	the
O	1686	1695	education
O	1696	1698	is
O	1699	1704	based
O	1705	1707	on
O	1708	1711	the
O	1712	1723	traditional
O	1724	1734	biomedical
O	1735	1743	approach
O	1743	1744	.

O	1745	1748	The
O	1749	1756	primary
O	1757	1764	outcome
O	1765	1774	parameter
O	1775	1777	is
B-outcome-Measure	1778	1782	pain
I-outcome-Measure	1782	1783	-
I-outcome-Measure	1783	1790	related
I-outcome-Measure	1791	1801	disability
I-outcome-Measure	1802	1803	1
I-outcome-Measure	1804	1808	year
I-outcome-Measure	1809	1814	after
I-outcome-Measure	1815	1822	surgery
O	1822	1823	.

O	1824	1833	Secondary
O	1834	1842	outcomes
O	1843	1850	related
O	1851	1853	to
B-outcome-Measure	1854	1859	other
I-outcome-Measure	1860	1870	dimensions
I-outcome-Measure	1871	1873	of
I-outcome-Measure	1874	1878	pain
O	1878	1879	,
B-outcome-Measure	1880	1888	physical
I-outcome-Measure	1888	1889	,
I-outcome-Measure	1890	1899	emotional
I-outcome-Measure	1900	1903	and
I-outcome-Measure	1904	1908	work
I-outcome-Measure	1908	1909	-
I-outcome-Measure	1909	1916	related
I-outcome-Measure	1917	1928	functioning
O	1929	1931	at
O	1932	1933	1
O	1933	1934	-
O	1934	1938	week
O	1938	1939	,
O	1940	1941	4
O	1941	1942	,
O	1943	1944	6
O	1944	1945	,
O	1946	1947	8
O	1947	1948	,
O	1949	1951	12
O	1952	1955	and
O	1956	1958	18
O	1959	1965	months
O	1966	1977	postsurgery
O	1977	1978	.

O	1979	1982	The
O	1983	1988	study
O	1989	1993	will
O	1994	1996	be
O	1997	2006	conducted
O	2007	2009	in
O	2010	2020	accordance
O	2021	2025	with
O	2026	2029	the
O	2030	2041	Declaration
O	2042	2044	of
O	2045	2053	Helsinki
O	2053	2054	.

O	2055	2059	This
O	2060	2068	protocol
O	2069	2072	has
O	2073	2077	been
O	2078	2086	approved
O	2087	2089	by
O	2090	2093	the
O	2094	2101	ethical
O	2102	2111	committee
O	2112	2114	of
O	2115	2118	the
O	2119	2129	University
O	2130	2139	Hospitals
O	2140	2142	of
O	2143	2149	Leuven
O	2149	2150	.

O	2151	2158	Results
O	2159	2163	will
O	2164	2166	be
O	2167	2179	disseminated
O	2180	2183	via
O	2184	2188	peer
O	2188	2189	-
O	2189	2197	reviewed
O	2198	2208	scientific
O	2209	2217	journals
O	2218	2221	and
O	2222	2235	presentations
O	2236	2238	at
O	2239	2249	congresses
O	2249	2250	.

O	2251	2262	NCT03351075
O	2262	2263	.
